Close menu




 

Fabian Lorenz

  • Small-Caps
  • Micro-Caps

For more than twenty years, the Cologne native has been intensively involved with the stock market, both professionally and privately. He is particularly passionate about national and international small and micro caps.

He first came into contact with the stock market and shares during his banking apprenticeship. After completing this in 2000, he gained his first journalistic experience in the editorial department of a financial portal. During his subsequent studies in business administration, he also worked in the area of investor relations.

Since then, he has remained true to the capital markets and is excited to report on every newly discovered interesting story - as well as on long-standing success stories.


Commented by Fabian Lorenz

Commented by Fabian Lorenz on November 17th, 2022 | 10:40 CET

Breaking news drives Nel ASA share: What are BioNTech and Kleos Space up to?

  • Space
  • Biotechnology

Growth stocks are currently celebrating a comeback. In particular, when there is also positive news from the company itself, as is the case with Nel ASA. The share of the hydrogen specialist increased by 40% within 4 weeks, and analysts see further potential for their "Top Pick". And then the Norwegians announced a cooperation with General Motors yesterday. BioNTech is also looking good from a chart and operational point of view. The cash box is full, allowing the Mainz-based company to increase production capacities. There is also something happening with space stocks. The valuation of Elon Musk's SpaceX is said to have risen by USD 25 billion in the latest round of financing, which should also improve the environment for Kleos Space. The specialist in space-based high-frequency reconnaissance is facing important weeks.

Read

Commented by Fabian Lorenz on November 10th, 2022 | 12:26 CET

Plug Power after the horror numbers, and what are Varta and Altech Advanced Materials doing?

  • Batteries
  • Electromobility
  • Investments

Climate change, high gas and oil prices and the dependence on "difficult" energy suppliers: There are many reasons why hydrogen and electromobility are among the undisputed topics of the future. Accordingly, shares from these sectors are popular with investors. Plug Power is one of the favorites. The Americans have disappointed (again) with their latest quarterly figures, but the share price is still rising, and analysts are also positive. Battery specialist Altech Advanced Materials is also currently doing well. The cooperation with Fraunhofer in the field of solid-state batteries is taking shape. Varta, on the other hand, is currently working on bottoming out, but analysts advise selling.

Read

Commented by Fabian Lorenz on November 9th, 2022 | 13:31 CET

BioNTech, Porsche and Pathfinder Ventures - Looking good

  • Camping
  • RV
  • Biotechnology

BioNTech's figures were convincing, and the chart looks good again. Porsche is doing well. Not all analysts see further price potential and the price targets diverge. However, a promotion to the DAX beckons. Pathfinder Ventures is also benefiting from surprisingly high demand. The winter camping resort offers are practically sold out. But first to BioNTech. After competitor Moderna had disappointed last week, the quarterly figures of the Mainz-based biotech Company were convincing. And due to the full pipeline, investors can expect a lively news flow in the coming year. Analysts are bullish.

Read

Commented by Fabian Lorenz on November 3rd, 2022 | 12:01 CET

BioNTech, Moderna and Defence Therapeutics right in the middle of the billion-dollar mRNA market! And Bayer?

  • Biotechnology
  • vaccine
  • Cancer

BioNTech and Moderna's mRNA-based vaccines have successfully contributed to the containment of the COVID-19 pandemic. This has helped the relatively new technology for developing vaccines and other drugs to make a breakthrough. According to Precedence Research market researchers, the mRNA therapeutics market is expected to exceed USD 128 billion by 2030. The average annual growth would be around 13%. German top dog BioNTech is betting heavily on vaccines to fight cancer, among other things. Defence Therapeutics is now also entering the billion-dollar market, continuing the positive newsflow of recent weeks. The Canadians are opening up their platform for mRNA research, and their valuation is anything but expensive. Bayer is also too cheap at the moment. Analysts at least see a good 50% price potential.

Read

Commented by Fabian Lorenz on November 2nd, 2022 | 12:34 CET

Gas price collapses: BASF, Porsche, Meta Materials in an upward trend

  • metamaterials
  • Investments
  • Technology

The sharp fall in gas prices is creating a good mood among investors. This week, the forward contract (TTF) for natural gas fell to below EUR 100 per MWh, its lowest level since June. This is fueling hopes that inflation will cool and the recession will be less severe. The direct beneficiary is, of course, BASF. In addition, a subsidiary is currently earning billions, and analysts see further price potential overall. According to them, the chemical group is currently "simply too cheap". This could also be the case with hot stock Meta Materials. Recently, new orders have given a boost to the share price. Should the Canadians continue the commercialization of the patent portfolio so successfully, significantly higher prices are possible. After the stuttering IPO, the Porsche share has stepped on the gas. But from the analysts' point of view, the air is slowly getting thinner.

Read

Commented by Fabian Lorenz on October 28th, 2022 | 12:54 CEST

BioNTech, Nel ASA and Desert Gold - Ripe for uptrend?

  • Mining
  • Gold
  • Hydrogen
  • Biotechnology

The profit warning at ITM Power sent shockwaves throughout the hydrogen sector. Does this mean that the friendly development of the Nel share of the past few days has already ended? Analysts see little potential, at least at present, but are optimistic for the long term. Goldman Sachs is also optimistic about the gold price. At least the chances for a rise to over USD 2,000 are better than for a renewed decline. Producers like Barrick Gold should profit from this, and explorers like Desert Gold even disproportionately. At BioNTech, there is currently no impetus for an upward trend, and analysts' price targets diverge considerably. However, rumors from the US are encouraging.

Read

Commented by Fabian Lorenz on October 27th, 2022 | 10:14 CEST

Buffett loves oil stocks: BP, Shell, Saturn Oil + Gas, K+S

  • Mining
  • Oil
  • Gas

Warren Buffett loves oil stocks. This year, he has invested billions in the industry. Chevron and Occidental Petroleum are among Berkshire Hathaway's seven largest holdings, and together they are even number two in the portfolio after Apple. Buffett likes business models with high cash flows and stable demand. And oil stocks offer both. This also fits with the statement by Goldmann Sachs that despite the high investments in renewable energies, the share of fossil energy has remained stable above 80% in the last 10 years. If you want to do it like investor legend Buffett, you should look at oil stocks such as BP, Shell or the almost ridiculously cheaply valued Canadian newcomer Saturn Oil & Gas. However, the German K+S is also hooked on oil, and the share is trending friendly.

Read

Commented by Fabian Lorenz on October 20th, 2022 | 13:01 CEST

Shares: Porsche does it like Tesla - Varta is not there, and Infinity Stone Ventures?

  • Mining
  • Lithium
  • Batteries
  • Electromobility

E-car specialists like BYD and Tesla have had them for a long time: their own gigafactories. German automakers have long neglected their own battery production. It is surprising because, with electromobility, energy storage is becoming the heart of every car. Here in Germany, Porsche is now stepping on the gas and accelerating the development of its battery production. This could become a model for the entire VW Group. Unfortunately, German battery hopeful Varta is again not involved in the project. The Company seems to be making no headway in its search for partners. No matter who builds the batteries, companies like Infinity Stone Ventures stand to benefit. The specialist for critical raw materials is currently stepping on the gas in its projects, and the positive newsflow should continue.

Read

Commented by Fabian Lorenz on October 19th, 2022 | 11:51 CEST

The problem solvers: Plug Power, BioNTech, Almonty Industries

  • Mining
  • Tungsten
  • Hydrogen
  • Biotechnology

Rarely have there been as many global crises and challenges as there are right now. In addition to the war in Ukraine, there is Corona, an arguably inevitable recession, and the energy crisis - not to mention long-standing challenges such as the fight against cancer and climate change. Companies want to help solve these problems, and BioNTech is one of these companies. The Wiesbaden-based Company was not only successful in the fight against COVID-19. They are currently taking on cancer. And the CEO has recently been very positive. Almonty Industries wants to help reduce dependence on raw materials from China and Russia, and one Company has already given it long-term purchase guarantees. And Plug Power wants to help solve the energy crisis and fight climate change. The recent numbers have disappointed, but analysts see upside potential. We look at the current performance of the three problem solvers.

Read

Commented by Fabian Lorenz on October 13th, 2022 | 12:34 CEST

Fear of the numbers at Nel ASA? Is the knot bursting at BYD and dynaCERT?

  • Hydrogen
  • renewableenergies
  • Electromobility

Climate change, high gas prices, high oil prices and dependence on "difficult" energy suppliers: There are many reasons why hydrogen and electromobility are among the undisputed topics of the future. Shares from these sectors are also among the absolute favorites of investors. But despite this, many share prices are currently on a downward trend. These include the shares of Nel ASA, BYD and dynaCERT. Is now the time to enter? There is an analyst recommendation for Nel, but the outlook for the quarterly figures next week is causing fear. BYD is shining with record sales and wants to take a division public. dynaCERT's technology for reducing CO2 emissions is being recognized more and more. The board expects a strong current quarter, and the discussion about climate targets in the transport industry speak for the Canadians.

Read